🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
🔴 Serious hazard — Reported risk: Výrobek obsahuje nadměrný objem tekutiny s nikotinem (30 ml) a nadměrnou koncentraci nikotinu (50 mg/ml). To může vést k náhodné konzumaci vysoké dávky nikotinu. Nikotin je akutně toxický a může ohrozit bezpečnost uživatele, zejména pokud přijde do kontaktu s pokožkou nebo je požit. Kromě toho výrobek neobsahuje informační leták. V důsledku toho spotřebitelé nemohou činit informovaná rozhodnutí týkající se bezpečného používání výrobku. Výrobek nesplňuje požadavky směrnice o tabákových výrobcích.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Stop of sales
Date of entry into force
02/03/2026
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): NIC SALTS
Risk Description (original English): The product has an excessive volume of nicotine-containing liquid (30 ml) and an excessive concentration of nicotine (50 mg/ml). This could lead to the accidental consumption of a high dose of nicotine. Nicotine is acutely toxic and can endanger the user’s safety, notably if the product comes into contact with the skin or is ingested. Additionally, the product lacks an information leaflet. As a consequence, consumers cannot make informed decisions regarding the safe use of the product.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.